alexa The Size and Number is Not Everything to Evaluate the Tumor Response | OMICS International| Abstract
ISSN: 2165-7920

Journal of Clinical Case Reports
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Clin Case Rep 2018, Vol 8(2): 1082
  • DOI: 10.4172/2165-7920.10001082

The Size and Number is Not Everything to Evaluate the Tumor Response

Erdem Sen1*, Irem Oner1, Farise Yılmaz2 and Ozlem Ata1
1Department of Medical Oncology, Selcuk University, Konya, Turkey
2Department of Nuclear Medicine, Selcuk University, Konya, Turkey
*Corresponding Author : Erdem Sen, Department of Medical Oncology, Selcuk University, Konya, Turkey, Tel: +903322244085, Fax: +903322416065, Email: [email protected]

Received Date: Jan 18, 2018 / Accepted Date: Feb 25, 2018 / Published Date: Mar 05, 2018


Gastrointestinal stromal tumors are the most common mesenchymal tumors of the gastrointestinal tract. Contrast-enhanced computed tomography is the most commonly used for evaluating response to treatment. Targeted therapies may cause some changes in tumor structure. Reduced lesion vascularity, cavitations, and intratumoral hemorrhage are some changes in patients after imatinib therapy, even without any size reduction. Paradoxically, a transient increase in size may be seen in some cases due to cystic change and intratumoral hemorrhage. Alternative tumor response criteria were developed by Choi et al. in gastrointestinal stromal tumor. They showed that not only the tumor size but also the tumor density are important in evaluating the response. In the present study, we report a 67-year old man who had been diagnosed with the gastrointestinal stromal tumor and treated with imatinib. After 3 months of imatinib treatment, liver lesions reported progression in response assessment.

Keywords:  Gastrointestinal stromal tumor; Imatinib; Choi criteria

Citation: Sen E, Oner I, Yilmaz F, Ata O (2018) The Size and Number is Not Everything to Evaluate the Tumor Response. J Clin Case Rep 8: 1082. Doi: 10.4172/2165-7920.10001082

Copyright: ©2018 Sen E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences

14th Global Pharmacovigilance And Clinical Trials Summit

Sydney, Australia

38th International Conference on Dental & Oral Care

Yokohama, Japan

World Conference on Clinical and Medical Case Reports

Perth, Australia
Article Usage
  • Total views: 1422
  • [From(publication date): 0-2018 - Jan 25, 2020]
  • Breakdown by view type
  • HTML page views: 1370
  • PDF downloads: 52